Virucidal Properties of Molecular Iodine Oral Rinse Against SARS-CoV-2.
Compend Contin Educ Dent
; 43(2): e13-e16, 2022 Feb.
Article
in English
| MEDLINE | ID: covidwho-1679201
ABSTRACT
BACKGROUND:
Saliva is an active carrier of SARS-CoV-2, and antimicrobial mouthrinses can be rendered less effective by saliva. Aerosol-generating procedures are commonplace in dentistry, and preprocedural mouthrinses and/or irrigation with effective SARS-CoV-2 virucidals should be tested in the presence of saliva.METHODS:
With the use of an in vitro virucidal suspension test, molecular iodine oral rinse was assayed against SARS-CoV-2 with and without saliva after 30- and 60-second exposures to the rinse. Log10 infectivity and consequent virus reductions were calculated at each timepoint.RESULTS:
Virus load reductions with saliva were 4.75 log10 after 30 seconds of exposure and ≥5.25 log10 after 60 seconds. Without saliva, infectivity was reduced by 5.00 log10 and ≥5.75 log10 after 30 and 60 seconds, respectively.CONCLUSIONS:
Molecular iodine oral rinse appears effective in reducing SARS-CoV-2 infectivity in vitro and, to date, appears to be the most effective oral rinse tested both in the presence of and without human saliva.
Search on Google
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Iodine
Limits:
Humans
Language:
English
Journal:
Compend Contin Educ Dent
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS